Aion Therapeutic Inc.
ANTCF
$0.0055
-$0.001-15.39%
| Weiss Ratings | ANTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | ANTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ANTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -2.44 | |||
| Price History | ANTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | -50.00% | |||
| 60-Day Total Return | 34.15% | |||
| 90-Day Total Return | -51.33% | |||
| Year to Date Total Return | -64.29% | |||
| 1-Year Total Return | -54.17% | |||
| 2-Year Total Return | -62.84% | |||
| 3-Year Total Return | -72.50% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -88.42% | |||
| 52-Week Low % Change | 57.14% | |||
| Price | ANTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.05 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Sep 24, 2024 | |||
| 52-Week High Price (Date) | Nov 05, 2024 | |||
| Valuation | ANTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.43M | |||
| Enterprise Value | 5.02M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | 171.11% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 3.24 | |||
| Price/Book (Q) | -0.93 | |||
| Enterprise Value/Revenue (TTM) | 6.08 | |||
| Price | $0.01 | |||
| Enterprise Value/EBITDA (TTM) | -4.67 | |||
| Enterprise Value/EBIT | -4.60 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ANTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 484.01M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ANTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 416 460 3000 | |||
| Address | 700 West Georgia Street Vancouver, BC V7Y 1K8 | |||
| Website | -- | |||
| Country | Canada | |||
| Year Founded | 2011 | |||
| Profitability | ANTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -132.25% | |||
| Profit Margin | -587.33% | |||
| Management Effectiveness | ANTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -103.82% | |||
| Return on Equity | -- | |||
| Income Statement | ANTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 843.90K | |||
| Total Revenue (TTM) | 843.90K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 341.00K | |||
| EBITDA (TTM) | -1.10M | |||
| EBIT (TTM) | -1.12M | |||
| Net Income (TTM) | -4.96M | |||
| Net Income Avl. to Common (TTM) | -4.96M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -219.46% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | -28.57% | |||
| Balance Sheet | ANTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 67.20K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 1.02M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -2.95M | |||
| Current Ratio (Q) | 0.252 | |||
| Book Value Per Share (Q) | -$0.01 | |||
| Total Assets (Q) | 1.11M | |||
| Total Current Liabilities (Q) | 4.05M | |||
| Total Debt (Q) | 1.73M | |||
| Total Liabilities (Q) | 4.05M | |||
| Total Common Equity (Q) | -2.95M | |||
| Cash Flow | ANTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -17.30K | |||
| Cash from Financing (TTM) | 897.90K | |||
| Net Change in Cash (TTM) | 69.50K | |||
| Levered Free Cash Flow (TTM) | -538.60K | |||
| Cash from Operations (TTM) | -922.50K | |||
